SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011128
Filing Date
2021-08-10
Accepted
2021-08-10 16:06:38
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20210630x10q.htm   iXBRL 10-Q 1804668
2 EX-31.1 lqda-20210630xex31d1.htm EX-31.1 15275
3 EX-31.2 lqda-20210630xex31d2.htm EX-31.2 15303
4 EX-32.1 lqda-20210630xex32d1.htm EX-32.1 7534
5 EX-32.2 lqda-20210630xex32d2.htm EX-32.2 7540
6 GRAPHIC lqda-20210630x10q001.jpg GRAPHIC 631
7 GRAPHIC lqda-20210630x10q002.jpg GRAPHIC 646
  Complete submission text file 0001558370-21-011128.txt   7509886

Data Files

Seq Description Document Type Size
8 EX-101.SCH lqda-20210630.xsd EX-101.SCH 52684
9 EX-101.CAL lqda-20210630_cal.xml EX-101.CAL 63424
10 EX-101.DEF lqda-20210630_def.xml EX-101.DEF 176869
11 EX-101.LAB lqda-20210630_lab.xml EX-101.LAB 488392
12 EX-101.PRE lqda-20210630_pre.xml EX-101.PRE 370999
13 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20210630x10q_htm.xml XML 1319273
Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 211159914
SIC: 2834 Pharmaceutical Preparations